Trial · NCT01848756
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With Adverse Events | SNX-5422 | 15 | participants | ||
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | All laboratory abnormalities | 8 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | ALT/AST increases | 6 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | Alkaline phosphatase increase | 3 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | Vital signs | 0 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | Systolic/diastolic blood pressure | 0 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | Respiratory rate | 0 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | Temperature | 0 | participants | |
| Changes in Vital Signs, Physical Examination or Clinical Laboratory From Baseline | SNX-5422 | ECG | 0 | participants | |
| Ophthalmologic Changes From Baseline | SNX-5422 | 1 | participants | ||
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with adverse events | 15 | participants | |
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with Grade 3 or 4 adverse events | 8 | participants | |
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with Grade 5 adverse events | 2 | participants | |
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with treatment related adverse events | 15 | participants | |
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with Grade 3 or 4 AEs related to treatmen | 7 | participants | |
| Adverse Events by Severity and Relationship to Treatment | SNX-5422 | Subjects with Grade 5 AEs related to treatment | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01848756/results